PLENARY SESSION // GENE EDITING

8:30 AM • S15L1 • Genome Editing for Duchenne Muscular Dystrophy > C. Charles GERSBACH (Durham, Usa) 9:00 AM • S15L2 • N=1 DMD Gene Editing > R. Richard HORGAN (Woodbridge, Ct, Usa) 9:30 AM • S15L3 • Human iPS-based disease models and CRISPR-Cas technology for the development of genetic therapies for LMNA­-related skeletal muscle laminopathies > D. Daniel MOORE (London, Uk) 9:45 AM • S15L4 • First correction by Prime editing of mutations in the RYR1 gene > J. Jacques P. TREMBLAY (Quebec, Canada)